SpringWorks Therapeutics, Inc. Common Stock (SWTX) is a publicly traded Healthcare sector company. As of May 20, 2026, SWTX trades at $46.99 with a market cap of $3.48B and a P/E ratio of -13.78. SWTX moved +0.00% today. Year to date, SWTX is +29.45%; over the trailing twelve months it is +25.21%. Its 52-week range spans $28.21 to $62.00. Analyst consensus is buy with an average price target of $47.00. Rallies surfaces SWTX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
SpringWorks Therapeutics, Inc. Common Stock (SWTX) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. SWTX moved +0.00% today. Analyst consensus is buy.
| Metric | Value |
|---|---|
| Price | $46.99 |
| Market Cap | $3.48B |
| P/E Ratio | -13.78 |
| EPS | $-3.41 |
| Dividend Yield | 0.00% |
| 52-Week High | $62.00 |
| 52-Week Low | $28.21 |
| Volume | 5.01M |
| Avg Volume | 0 |
| Revenue (TTM) | $219.67M |
| Net Income | $-253.93M |
| Gross Margin | 93.23% |
11 analysts cover SWTX: 0 strong buy, 7 buy, 4 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $47.00.